Margaret H. Hastings PhD , Claire Castro PhD , Rebecca Freeman BA , Azrul Abdul Kadir PhD , Carolin Lerchenmüller MD , Haobo Li PhD , James Rhee MD, PhD , Jason D. Roh MD, MHS , Kangsan Roh PhD , Anand P. Singh PhD , Chao Wu MD, PhD , Peng Xia PhD , Qiulian Zhou PhD , Junjie Xiao MD, PhD , Anthony Rosenzweig MD
{"title":"运动对心脏有益的内在和外在因素","authors":"Margaret H. Hastings PhD , Claire Castro PhD , Rebecca Freeman BA , Azrul Abdul Kadir PhD , Carolin Lerchenmüller MD , Haobo Li PhD , James Rhee MD, PhD , Jason D. Roh MD, MHS , Kangsan Roh PhD , Anand P. Singh PhD , Chao Wu MD, PhD , Peng Xia PhD , Qiulian Zhou PhD , Junjie Xiao MD, PhD , Anthony Rosenzweig MD","doi":"10.1016/j.jacbts.2023.07.011","DOIUrl":null,"url":null,"abstract":"<div><p>Among its many cardiovascular benefits, exercise training improves heart function and protects the heart against age-related decline, pathological stress, and injury. Here, we focus on cardiac benefits with an emphasis on more recent updates to our understanding. While the cardiomyocyte continues to play a central role as both a target and effector of exercise’s benefits, there is a growing recognition of the important roles of other, noncardiomyocyte lineages and pathways, including some that lie outside the heart itself. We review what is known about mediators of exercise’s benefits—both those intrinsic to the heart (at the level of cardiomyocytes, fibroblasts, or vascular cells) and those that are systemic (including metabolism, inflammation, the microbiome, and aging)—highlighting what is known about the molecular mechanisms responsible.</p></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":null,"pages":null},"PeriodicalIF":8.4000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452302X23002942/pdfft?md5=48d166bf1f1061b3bc98170a1187c0e0&pid=1-s2.0-S2452302X23002942-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Intrinsic and Extrinsic Contributors to the Cardiac Benefits of Exercise\",\"authors\":\"Margaret H. Hastings PhD , Claire Castro PhD , Rebecca Freeman BA , Azrul Abdul Kadir PhD , Carolin Lerchenmüller MD , Haobo Li PhD , James Rhee MD, PhD , Jason D. Roh MD, MHS , Kangsan Roh PhD , Anand P. Singh PhD , Chao Wu MD, PhD , Peng Xia PhD , Qiulian Zhou PhD , Junjie Xiao MD, PhD , Anthony Rosenzweig MD\",\"doi\":\"10.1016/j.jacbts.2023.07.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Among its many cardiovascular benefits, exercise training improves heart function and protects the heart against age-related decline, pathological stress, and injury. Here, we focus on cardiac benefits with an emphasis on more recent updates to our understanding. While the cardiomyocyte continues to play a central role as both a target and effector of exercise’s benefits, there is a growing recognition of the important roles of other, noncardiomyocyte lineages and pathways, including some that lie outside the heart itself. We review what is known about mediators of exercise’s benefits—both those intrinsic to the heart (at the level of cardiomyocytes, fibroblasts, or vascular cells) and those that are systemic (including metabolism, inflammation, the microbiome, and aging)—highlighting what is known about the molecular mechanisms responsible.</p></div>\",\"PeriodicalId\":14831,\"journal\":{\"name\":\"JACC: Basic to Translational Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.4000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2452302X23002942/pdfft?md5=48d166bf1f1061b3bc98170a1187c0e0&pid=1-s2.0-S2452302X23002942-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Basic to Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452302X23002942\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X23002942","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Intrinsic and Extrinsic Contributors to the Cardiac Benefits of Exercise
Among its many cardiovascular benefits, exercise training improves heart function and protects the heart against age-related decline, pathological stress, and injury. Here, we focus on cardiac benefits with an emphasis on more recent updates to our understanding. While the cardiomyocyte continues to play a central role as both a target and effector of exercise’s benefits, there is a growing recognition of the important roles of other, noncardiomyocyte lineages and pathways, including some that lie outside the heart itself. We review what is known about mediators of exercise’s benefits—both those intrinsic to the heart (at the level of cardiomyocytes, fibroblasts, or vascular cells) and those that are systemic (including metabolism, inflammation, the microbiome, and aging)—highlighting what is known about the molecular mechanisms responsible.
期刊介绍:
JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.